PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
PepGen Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.70+0.10 (+3.85%)
Close on Oct 19, 2026
- Market cap
- $186.85M
- P/E (TTM)
- –
- Dividend yield
- –